Innospec Inc.
NASDAQ:IOSPChemicals - Specialty
+$0.08 today
- Market cap
- $1.94B
- Beta
- 0.91
- P/E (TTM)
- 18.0
- EPS (TTM)
- $4.61
- Dividend yield
- 2.15%
Volume 0.23M
Average 0.24M
IOSP Income Tax Expense
Income taxes recognized for the period, including current and deferred tax.
Innospec Inc.NASDAQ: IOSP
Income Tax Expense · Q2 FY2026 · quarter ended Jun 2026
Income tax expense grows, but more slowly than its trailing trend
Q2 FY2026 income tax expense of $10.4M rose 23.8% year over year, behind the +2725.0% change in trailing-twelve-month income tax expense. Sequentially, it rose 14.3% from the prior quarter. Over 3 fiscal years it compounded at -25.3% a year.
Context
- Income tax expense amounted to 1.2% of revenue in FY2025, up 0.9 pp from a year earlier.
- Income tax expense increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +23.8% toward the trailing-twelve-month pace of +2725.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Income Tax Expense history
USD · from the income statement
- Latest · FY2025
- 21.5M USD
- Year-over-year change
- +283.9%
- 4-year CAGR
- -15.1%
| Period | Period end | Income Tax Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21.5M | +283.9% |
| FY2024 | 2024-12-31 | 5.6M | -84.1% |
| FY2023 | 2023-12-31 | 35.3M | -31.6% |
| FY2022 | 2022-12-31 | 51.6M | +24.9% |
| FY2021 | 2021-12-31 | 41.3M | — |
Income Tax Expense vs competitors
How IOSP compares with its peers on the latest reported figures
- IOSP's LTM Jun 2026 income tax expense of $21M is the 8th highest of the 10 companies compared; the peer median is $50M.
- Its year-over-year change of +2725.0% is the highest of 10, against a peer median of +3.8%.
- Income tax expense amounts to 1.1% of revenue for IOSP, versus a peer median of 2.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $190M | +54.5% | +24.3% | 5.2% | |
| LTM Jun 2026 | $137.38M | +1.8% | +27.6% | 5.0% | |
| LTM Jun 2026 | $95M | -42.1% | -19.9% | 1.1% | |
| LTM Aug 2026 | $69.59M | +10.3% | -4.5% | 2.0% | |
| LTM Jun 2026 | $50M | +484.6% | -19.6% | 2.7% | |
| LTM Sep 2026 | $30.55M | +3.8% | +7.2% | 2.7% | |
| LTM Sep 2026 | $28.7M | +2.4% | -0.4% | 1.4% | |
| LTM Jun 2026 | $21M | +2725.0% | -25.3% | 1.1% | |
| LTM Mar 2026 | $167K | +2187.5% | — | 0.2% | |
| LTM Sep 2026 | -$121.8M | -194.2% | — | 2.3% | |
| Peer median (excluding IOSP) | $50M | +3.8% | -0.4% | 2.3% | |
Competitors are the stored peer set for IOSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.48B | 1.96B | 1.95B | 1.85B | 1.78B |
| Cost of Revenue | 1.05B | 1.38B | 1.36B | 1.3B | 1.29B |
| Gross Profit | 434.9M | 586.7M | 591.1M | 542.9M | 492.4M |
| Gross Margin | 29.3% | 29.9% | 30.3% | 29.4% | 27.7% |
| Research & Development | 37.4M | 38.7M | 41.7M | 47.8M | 51M |
| Selling, General & Admin | 267.2M | 360.7M | 387.8M | 314M | 285.1M |
| Operating Expenses | 302.8M | 399.4M | 429.5M | 365M | 336.1M |
| Depreciation & Amortization | 42.7M | 40.1M | 39.3M | 43.5M | 43.6M |
| EBITDA | 173M | 225.8M | 213.7M | 224.6M | 181.7M |
| EBITDA Margin | 11.7% | 11.5% | 11.0% | 12.2% | 10.2% |
| Operating Income | 132.1M | 187.3M | 161.6M | 177.9M | 156.3M |
| Operating Margin | 8.9% | 9.5% | 8.3% | 9.6% | 8.8% |
| Interest Income | 0 | 0 | 0 | 0 | 9.2M |
| Interest Expense | 1.5M | 1.1M | 0 | 0 | 0 |
| Other Income / Expenses | 2.3M | (2.7M) | 12.8M | (136.7M) | (18.2M) |
| Income Before Tax | 134.4M | 184.6M | 174.4M | 41.2M | 138.1M |
| Pre-Tax Margin | 9.1% | 9.4% | 8.9% | 2.2% | 7.8% |
| Income Tax Expense | 41.3M | 51.6M | 35.3M | 5.6M | 21.5M |
| Net Income | 93.1M | 133M | 139.1M | 35.6M | 116.6M |
| Net Margin | 6.3% | 6.8% | 7.1% | 1.9% | 6.6% |
| EPS (Basic) | 3.78 | 5.37 | 5.60 | 1.43 | 4.69 |
| EPS (Diluted) | 3.75 | 5.32 | 5.56 | 1.42 | 4.67 |
| Weighted Avg Shares | 24.65M | 24.79M | 24.85M | 24.93M | 24.88M |
| Weighted Avg Shares (Diluted) | 24.85M | 24.98M | 25.02M | 25.12M | 24.99M |
Innospec Inc.
NASDAQ:IOSP
Intrinsic Alpha fair value
Locked
Current Price
$78.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.